Patent Number: 8,871,800

Title: Statin and omega-3 fatty acids for reduction of Apo-B levels

Abstract: Methods of utilizing a combined administration or a unit dosage of a combination of an HMG-CoA inhibitor and omega-3 fatty acids for the reduction of apolipoprotein-B levels. The methods are especially useful in the treatment of patients with hypertriglyceridemia or hypercholesterolemia or mixed dyslipidemia, coronary heart disease (CHD), vascular disease, atherosclerotic disease and related conditions, and for the prevention or reduction of cardiovascular, cardiac, and vascular events.

Inventors: Rongen; Roelof M. L. (Califon, NJ), Shalwitz; Robert A. (Bexley, OH), Kling; Douglas (Parsippany, NJ), Doyle, Jr.; Ralph T. (Milford, NJ)

Assignee: GlaxoSmithKline, LLC

International Classification: A61K 31/202 (20060101); A61K 31/351 (20060101)

Expiration Date: 2018-10-28 0:00:00